daily coverage of the optics & photonics industry and the markets that it serves
Historical Archive

Psoriasis laser gets FDA approval

17 Jun 2002

The US Food & Drug Administration (FDA) has approved a new laser treatment for the skin disorder psoriasis, according to the manufacturer, Candela.

The company plans to start marketing the system, which is currently undergoing clinical trials, this summer. Gerard Puorro, Candela's president, said: "Following acne, psoriasis is the second most common skin disorder in the US. The market is underserved by current treatments."

Diverse Optics Inc.LightTrans International GmbHOmicron-Laserage Laserprodukte GmbHAVANTES BVFocuslight TechnologiesSPECTROGON ABUniverse Kogaku America Inc.
Copyright © 2022 SPIE EuropeDesigned by Kestrel Web Services